Biblio Discovery — Demo Discovery Service

7 results for "Benjamin Kimble"

Showing 1–7 · 2.44 seconds · RSS

  1. Journal Article Full text

    Pharmacokinetic profile of injectable tramadol in the koala ( Phascolarctos cinereus ) and prediction of its analgesic efficacy

    Benjamin Kimble; Larry Vogelnest; Peter Valtchev et al.

    PLOS ONE, Vol. 16 No. 3 · 2021 · English · PLOS Scopus

    Tramadol is used as an analgesic in humans and some animal species. When tramadol is administered to most species it undergoes metabolism to its main metabolites M1 or O-desmethyltramadol, and M2 or N-desmethyltramadol, and many other metabolites. This study describes the pharmacokinetic profile of…

  2. Journal Article Full text

    Assay validation and determination of in vitro binding of mefloquine to plasma proteins from clinically normal and FIP-affected cats

    Aaron M. Izes; Benjamin Kimble; Jacqueline M. Norris et al.

    PLOS ONE, Vol. 15 No. 8 · 2020 · English · PLOS Scopus

    The antimalarial agent mefloquine is currently being investigated for its potential to inhibit feline coronavirus and feline calicivirus infections. A simple, high pressure liquid chromatography assay was developed to detect mefloquine plasma concentrations in feline plasma. The assay’s lower limit…

  3. Journal Article Full text

    In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum ( Trichosurus vulpecula )

    Aaron Michael Izes; Benjamin Kimble; Jacqueline Marie Norris et al.

    PLOS ONE, Vol. 15 No. 4 · 2020 · English · PLOS Scopus

    Feline infectious peritonitis (FIP) is a systemic, fatal, viral-induced, immune-mediated disease of cats caused by feline infectious peritonitis virus (FIPV). Mefloquine, a human anti-malarial agent, has been shown to inhibit FIPV in vitro. As a first step to evaluate its efficacy and safety…

  4. Journal Article Full text

    Pharmacokinetic profile of oral and subcutaneous administration of paracetamol in the koala ( Phascolarctos cinereus ) and prediction of its analgesic efficacy

    Merran Govendir; Larry Vogelnest; Amanda J. Shapiro et al.

    PLOS ONE, Vol. 19 No. 4 · 2024 · English · PLOS Scopus

    The pharmacokinetic profile of paracetamol in koalas is described when administered orally at 15 mg/kg; followed by the same dose, administered every 12 hours (hrs), repeated five times. After the initial oral administration, the median (range) maximal plasma concentration (Cmax), the time Cmax was…

  5. Journal Article Full text

    Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep

    Alyssa N. Woodland; Dominique Van der Saag; Benjamin Kimble et al.

    PLOS ONE, Vol. 14 No. 4 · 2019 · English · PLOS Scopus

    Plasma pharmacokinetic profiles and the anti-inflammatory efficacy of meloxicam were determined when administered subcutaneously (SC) or intramuscularly (IM) to sheep. Merino ewes were initially injected with 0.1 mL of oil of turpentine into a forelimb to induce inflammation, followed by either 1.0…

  6. Journal Article Full text

    Pharmacokinetic profile of oral firocoxib in the koala ( Phascolarctos cinereus )

    Amanda June Shapiro; Benjamin Kimble; Frances Hulst et al.

    PLOS One, Vol. 20 No. 9 · 2025 · English · PLOS Scopus

    The pharmacokinetic profile of firocoxib administered orally at 5 mg/kg as a single dose to three mature koalas of each sex is described. After single dose administration, the harmonic means for maximal plasma concentration (Cmax), time to reach Cmax (Tmax) and elimination half-life (t1/2) were…

  7. Journal Article Full text

    Preliminary analyses of tryptophan, kynurenine, and the kynurenine: Tryptophan ratio in plasma, as potential biomarkers for systemic chlamydial infections in koalas

    Chien-Jung Chen; Benjamin Kimble; Astrid Van Aggelen et al.

    PLOS ONE, Vol. 19 No. 12 · 2024 · English · PLOS Scopus

    Chlamydiosis is the major infectious disease responsible for significant morbidity and mortality in free-living koalas. Recently, it was reported that 28.5% of koalas infected with chlamydiosis were presented with no overt clinical signs. Identification and quantification of changes in plasma…